Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Angelalign TechnologyHKSE:06699 +0.42%94 OCF Margin % is 23.08% as of Jun. 2026, which is 9% below its 10-year median of 25.41. GuruFocus rates HKSE:06699 with a GF Score™ of 94/100 and a GF Value™ of HK$103.94 (Fairly Valued). The stock has 6 warning signs investors should review. Among 813 Medical Devices & Instruments companies, Angelalign Technology ranks better than 89.3% on this metric.
The historical rank and industry rank for Angelalign Technology's OCF Margin % or its related term are showing as below:
HKSE:06699'
s OCF Margin % Range Over the Past 10 Years
Min: 6.29 Med: 25.41 Max: 62.29
Current: 25.98
During the past 8 years, the highest OCF Margin % of Angelalign Technology was 62.29%. The lowest was 6.29%. And the median was 25.41%.
HKSE:06699's OCF Margin % is ranked better than 89.3% of 813
companies
in the Medical Devices & Instruments industry
Industry Median: 6.51
vs HKSE:06699: 25.98
Angelalign Technology OCF Margin % Historical Data
* Premium members only.
The historical data trend for Angelalign Technology's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:06699 vs ISRG, BDX, RMD: OCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Angelalign Technology's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Angelalign Technology OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Angelalign Technology's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Angelalign Technology's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Angelalign Technology (HKSE:06699) has a OCF Margin % of 23.08% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Angelalign Technology and its competitors. This is near median its historical median of 25.41. Over the past decade, Angelalign Technology's OCF Margin % has ranged from 6.29 to 62.29. According to the industry distribution chart, Angelalign Technology ranks #87 out of 813 companies in the Medical Devices & Instruments industry, placing it in the top 10.7%.
Is Angelalign Technology's OCF Margin % too high?
Angelalign Technology's current OCF Margin % of 23.08% is near median its 10-year median of 25.41. Over the past 10 years, this metric has ranged from a low of 6.29 to a high of 62.29. The Medical Devices & Instruments industry median OCF Margin % is 6.51. Angelalign Technology's value of 23.08% is 254.5% above this industry median. Based on the distribution chart, Angelalign Technology ranks #87 out of 813 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Angelalign Technology has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Angelalign Technology's OCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Angelalign Technology ranks #87 out of 813 companies for OCF Margin %. This places Angelalign Technology in the top 11% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 6.51. Angelalign Technology's value of 23.08% is 254.5% above this benchmark. Historically, Angelalign Technology's own OCF Margin % has ranged from 6.29 to 62.29 over the past decade. While the company's 10-year median is 25.41 vs. the industry median of 6.51, Angelalign Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 6.51, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Angelalign Technology's current OCF Margin % of 23.08% is 254.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Angelalign Technology and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 6.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Angelalign Technology's current OCF Margin % is 23.08%, which is near median its own 10-year median of 25.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Angelalign Technology stock overvalued right now?
Based on GuruFocus' analysis, Angelalign Technology (HKSE:06699) is currently considered Fairly Valued. The stock's GF Value™ is HK$103.94, compared to a current price of HK$96.50 — trading 7.2% below its estimated fair value. The current OCF Margin % is 23.08%, which is near median its 10-year median of 25.41 and 254.5% above the Medical Devices & Instruments industry median of 6.51. Angelalign Technology's overall GF Score™ is 94/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Angelalign Technology (HKSE:06699), the current OCF Margin % is 23.08% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Angelalign Technology (HKSE:06699) Overvalued in 2026?
Based on GuruFocus' analysis, Angelalign Technology stock appears to be undervalued.
The current stock price of HK$96.50 is trading 7.2% below its estimated GF Value™ of HK$103.94.
GuruFocus considers Angelalign Technology to be Fairly Valued.
Key valuation signals for HKSE:06699:
OCF Margin %: 23.08% (near median its 10-year median of 25.41)
GF Value™: HK$103.94 vs. price of HK$96.50 (7.2% below fair value)
Industry Position: 254.5% above the Medical Devices & Instruments median (#87 of 813)
No single metric tells the full story. See the HKSE:06699 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Angelalign Technology Inc is an investment holding company. It is principally engaged in clear aligner treatment solutions, including treatment planning services, manufacturing, and marketing of clear aligners. The company provides dental professionals with self-developed digital orthodontic solutions. The company's Angelalign clear aligner system facilitates dental professionals throughout the entire clear aligner treatment process, including digitally-assisted case assessment support and treatment planning services, provide dental professionals with digitally-assisted case assessment support and treatment planning services, and helps dental professionals design, review, and modify treatment plans.
94GF Score
Get the complete analysis for HKSE:06699
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06699 has been successfully added to your 
